For the Inventor, By the Inventor

Enter assignee name

Chu Nantes

Calculating rank

USPTO Granted Patents = 18

% Expired Patents = 22.2

CIPO Patents = 2

EPO Patents = 20

Forward Citations = 22

Loading Chart...

Loading Chart...

53 inventors (with patents filed for the assignee):

Pierre Weiss (4 out of 9 patents)

Nicole Brument (3 out of 3 patents)

Jérôme Guicheux (3 out of 8 patents)

4. Vincent Sauzeau (2 out of 3 patents)

5. Gervaise Loirand (2 out of 3 patents)

6. Nathalie Labarriere (2 out of 5 patents)

7. Agnes Moreau-Aubry (2 out of 2 patents)

8. Yann Godet (2 out of 2 patents)

9. Jacques Lebreton (2 out of 4 patents)

10. Arnaud Tessier (2 out of 3 patents)

11. Brigitte Dreno (1 out of 1 patent)

12. Soraya Saiagh (1 out of 1 patent)

13. Thomas Zuliani (1 out of 1 patent)

14. Dominique Heymann (1 out of 4 patents)

15. Antoine Magnan (1 out of 6 patents)

18 patents: Sort by Forward Citations

1. 12708698 - Formulation comprising a phosphocalcic cement and a physical and/or covalent hydrogel of polysaccharides, printable and having ductile mechanical properties for bone regeneration/bone repair (2026-08-18),

2. 12351832 - Recombinant adeno-associated virus particle purification with multiple-step anion exchange chromatography (2025-07-08),

3. 11932638 - Ion channel inhibitor compounds for cancer treatment (2024-03-19),

4. 11795144 - Inhibitors of RAC1 and uses thereof for treating cancers (2023-10-24),

5. 11761960 - CD24CD38transitional B cells and CD9 as new biomarker of long-term human lung allograft survival (2023-09-19),

6. 11607419 - Inhibitors of RAC1 and uses thereof for inducing bronchodilatation (2023-03-21),

7. 11351201 - Bandage containing foetal fibroblasts and keratinocytes (2022-06-07),

8. 11203740 - Recombinant adeno-associated virus particle purification with multiple-step anion exchange chromatography (2021-12-21),

9. 11021689 - Recombinant adeno-associated virus particle purification comprising an affinity purification step (2021-06-01),

10. 10703813 - Anti IL-34 antibodies (2020-07-07),

11. 10632154 - Si-HPMC-encapsulated insulin-producing cells for the treatment of type 1 diabetes (2020-04-28),

12. 9968681 - Silylated biomolecule-based hydrogel for culturing cardiomyocytes and stem cells, and use of the hydrogel thereof for treating heart failure (2018-05-15),

13. 9724144 - Bone regeneration membrane and method for forming a bone regeneration membrane (2017-08-08),

14. 9290421 - Hypervalent radioactive astatine or iodine compounds, and preparation methods thereof (2016-03-22),

15. 9285360 - Silylated biomolecules (2016-03-15),

Company Overview

Chu Nantes is a prominent healthcare institution located in Nantes, France, specializing in a wide range of medical services and research initiatives. The organization is dedicated to advancing patient care through innovative medical practices and cutting-edge research in various fields, including oncology, cardiology, and neurology. With a strong emphasis on collaboration, Chu Nantes engages in partnerships with academic and research institutions to foster advancements in medical technology and improve healthcare outcomes in the region.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

18 Patents

#6 in Nantes

#1,097 in France

#34,244 in the World

Chu Nantes

Forward Citations = 22

53 inventors:

Pierre Weiss (4 out of 9 patents)

Nicole Brument (3 out of 3 patents)

Jérôme Guicheux (3 out of 8 patents)

4. Vincent Sauzeau (2 out of 3 patents)

5. Gervaise Loirand (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Chu Nantes. Retrieved from https://idiyas.com/company/chu-nantes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…